NCT07376382 2026-02-02SYNSTAR-02CSPC Megalith Biopharmaceutical Co.,Ltd.Phase 3 Not yet recruiting450 enrolled
NCT05773092 2025-09-03A Phase 2 Study of Osimertinib and S-1 in Treatment Resistant EGFR Mutant NSCLCNational Cancer Centre, SingaporePhase 2 Active not recruiting30 enrolled